9d
MedPage Today on MSNApproved Sickle Cell Drug Fails to Beat Placebo in TrialCrizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
“You might carry the gene (or trait) for sickle cell disorder and not even know it,” says Virginia Tshibangu, a Clinical ...
6d
HealthDay on MSNFirst Patient Cured of Sickle Cell AnemiaFor 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia.Now, thanks to a groundbreaking ge ...
Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he ...
1d
The Punch on MSNI hid my genotype from friends to avoid stigma – Lead City University first-class graduate with sickle cellThere was a time during my second year when I was supposed to sit for a test, and that was the first time I had to be ...
A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. For 21 years, Sebastien Beauzile suffered chronic pain ...
LONG ISLAND, NY (WCBS) - A 21-year-old man has become the first in New York to be cured of sickle cell anemia. “We feel ...
"When we could use Sebastien's own stem cells to do this therapy, we were delighted," Dr. Banu Aygun said. "Sickle cell disease was described in modern medicine in 1910, and here we are over 100 ...
irrespective of hydroxyurea use and sickle cell genotype. SUSTAIN was the basis for FDA approval and European Medicines Agency (EMA) approval for crizanlizumab for the prevention of vaso-occlusive ...
7d
WPHL Philadelphia on MSNProposed NJ bill could allow medical cannabis for sickle cell patientsAnyone living with sickle cell anemia is a warrior, Leslie Davis-Primo will tell you. “I’ve had three children, largely ...
Esther Nkemakolam runs her fingers through kinetic sand and sings a “Moana” song as UPMC Children’s Hospital nurse Taylor Brennan gets to work drawing blood. Esther is back for her monthly blood ...
Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results